These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 28090570)

  • 1. Targeted inhibition of pancreatic acinar cell calcineurin is a novel strategy to prevent post-ERCP pancreatitis.
    Orabi AI; Wen L; Javed TA; Le T; Guo P; Sanker S; Ricks D; Boggs K; Eisses JF; Castro C; Xiao X; Prasadan K; Esni F; Gittes GK; Husain SZ
    Cell Mol Gastroenterol Hepatol; 2017 Jan; 3(1):119-128. PubMed ID: 28090570
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Exposure to Radiocontrast Agents Induces Pancreatic Inflammation by Activation of Nuclear Factor-κB, Calcium Signaling, and Calcineurin.
    Jin S; Orabi AI; Le T; Javed TA; Sah S; Eisses JF; Bottino R; Molkentin JD; Husain SZ
    Gastroenterology; 2015 Sep; 149(3):753-64.e11. PubMed ID: 25980752
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Transient High Pressure in Pancreatic Ducts Promotes Inflammation and Alters Tight Junctions via Calcineurin Signaling in Mice.
    Wen L; Javed TA; Yimlamai D; Mukherjee A; Xiao X; Husain SZ
    Gastroenterology; 2018 Oct; 155(4):1250-1263.e5. PubMed ID: 29928898
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Preclinical safety evaluation of calcineurin inhibitors delivered through an intraductal route to prevent post-ERCP pancreatitis demonstrates endocrine and systemic safety.
    Ni J; Khalid A; Lin YC; Barakat MT; Wang J; Tsai CY; Azar PRS; Ding Y; Murayi JA; Jayaraman T; Poropatich R; Bottino R; Wen L; Papachristou GI; Swaminathan G; Yu M; Husain SZ
    Pancreatology; 2023 Jun; 23(4):333-340. PubMed ID: 37031049
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Protective Effects of Calcineurin on Pancreatitis in Mice Depend on the Cellular Source.
    Wen L; Javed TA; Dobbs AK; Brown R; Niu M; Li L; Khalid A; Barakat MT; Xiao X; Yimlamai D; Konnikova L; Yu M; Byersdorfer CA; Husain SZ
    Gastroenterology; 2020 Sep; 159(3):1036-1050.e8. PubMed ID: 32445858
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Endoscopic pancreatic duct stents reduce the incidence of post-endoscopic retrograde cholangiopancreatography pancreatitis in high-risk patients.
    Sofuni A; Maguchi H; Mukai T; Kawakami H; Irisawa A; Kubota K; Okaniwa S; Kikuyama M; Kutsumi H; Hanada K; Ueki T; Itoi T
    Clin Gastroenterol Hepatol; 2011 Oct; 9(10):851-8; quiz e110. PubMed ID: 21749851
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Preventative Effect of Nafamostat Mesilate Infusion into the Main Pancreatic Duct on Post-ERCP Pancreatitis in a Porcine Model: Initial Pilot Study.
    Park JS; Jeong S; Kim JM; Lee DH
    J Invest Surg; 2020 Apr; 33(4):325-331. PubMed ID: 30884994
    [No Abstract]   [Full Text] [Related]  

  • 8. Prophylactic pancreatic stent placement and post-ERCP pancreatitis: a systematic review and meta-analysis.
    Mazaki T; Masuda H; Takayama T
    Endoscopy; 2010 Oct; 42(10):842-53. PubMed ID: 20886403
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Suppository naproxen reduces incidence and severity of post-endoscopic retrograde cholangiopancreatography pancreatitis: Randomized controlled trial.
    Mansour-Ghanaei F; Joukar F; Taherzadeh Z; Sokhanvar H; Hasandokht T
    World J Gastroenterol; 2016 Jun; 22(21):5114-21. PubMed ID: 27275104
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The number of wire placement in the pancreatic duct and metal biliary stent as risk factors for post-endoscopic retrograde cholangiopancreatography pancreatitis.
    Shin SH; So H; Cho S; Kim N; Baik GH; Lee SK; Park DH
    J Gastroenterol Hepatol; 2020 Jul; 35(7):1201-1207. PubMed ID: 31830336
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Analysis of risk factors and prevention strategies of post-ERCP pancreatitis.
    Lin Y; Liu X; Cao DQ; Tang JH; Wen JJ; Li TF; Liu PF; Xia TS
    Eur Rev Med Pharmacol Sci; 2017 Nov; 21(22):5185-5190. PubMed ID: 29228432
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Endoscopic sphincterotomy to prevent post-ERCP pancreatitis in patients with biliary neoplasms: a multicenter retrospective cohort study.
    Tamura T; Ogura T; Takenaka M; Tanioka K; Itonaga M; Yamao K; Kamata K; Hirono S; Okada KI; Imanishi M; Higuchi K; Yamaue H; Kitano M
    Endosc Int Open; 2020 Apr; 8(4):E513-E522. PubMed ID: 32258373
    [No Abstract]   [Full Text] [Related]  

  • 13. Pancreatic stenting to prevent post-ERCP pancreatitis: a randomized multicenter trial.
    Phillip V; Pukitis A; Epstein A; Hapfelmeier A; Haf D; Schwab M; Demir IE; Rosendahl J; Hoffmeister A; Schmid RM; Weber A; Algül H
    Endosc Int Open; 2019 Jul; 7(7):E860-E868. PubMed ID: 31281872
    [No Abstract]   [Full Text] [Related]  

  • 14. Post-endoscopic retrograde cholangiopancreatography pancreatitis: A systematic review for prevention and treatment.
    Pekgöz M
    World J Gastroenterol; 2019 Aug; 25(29):4019-4042. PubMed ID: 31413535
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Factors associated with post-ERCP pancreatitis and the effect of pancreatic duct stenting in a pediatric population.
    Troendle DM; Abraham O; Huang R; Barth BA
    Gastrointest Endosc; 2015; 81(6):1408-16. PubMed ID: 25686874
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The safety and benefit of pancreatic juice cytology under ERCP in IPMN patients.
    Yoshioka T; Shigekawa M; Yamai T; Suda T; Kegasawa T; Iwahashi K; Ikezawa K; Sakamori R; Yakushijin T; Hiramatsu N; Tatsumi T; Takehara T
    Pancreatology; 2016; 16(6):1020-1027. PubMed ID: 27567445
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Risk factors for post-ERCP pancreatitis and hyperamylasemia: A retrospective single-center study.
    He QB; Xu T; Wang J; Li YH; Wang L; Zou XP
    J Dig Dis; 2015 Aug; 16(8):471-8. PubMed ID: 25955444
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Emerging Therapies to Prevent Post-ERCP Pancreatitis.
    Thiruvengadam NR; Kochman ML
    Curr Gastroenterol Rep; 2020 Nov; 22(12):59. PubMed ID: 33188441
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical study on the prevention of post-ERCP pancreatitis by pancreatic duct stenting.
    Pan XP; Dang T; Meng XM; Xue KC; Chang ZH; Zhang YP
    Cell Biochem Biophys; 2011 Dec; 61(3):473-9. PubMed ID: 21739262
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Reduced risk of post ERCP pancreatitis in statin users.
    Hadi YB; Naqvi SF; Abdelqader A; Kupec J; Nasr J
    BMC Gastroenterol; 2020 Apr; 20(1):125. PubMed ID: 32326889
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.